Notify me when Coastlands Capital Partners LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics, Inc. | Common Stock | 9.3% | $3,632,511 | 2,815,900 | Coastlands Capital LP | 28 May 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|